Search Results for: G1 Therapeutics AstraZeneca Enter Clinical
Articles
G1 Therapeutics & AstraZeneca Enter Clinical Trial Collaboration November 28, 2017
G1 Therapeutics, Inc. recently announced a clinical trial collaboration with AstraZeneca to evaluate AstraZeneca’s epidermal growth factor receptor (EGFR) tyrosine...Sania Therapeutics Launches to Advance Novel Medicines for Neural Circuit Dysfunction May 17, 2023
Sania Therapeutics, focused on developing genetic medicines for neural circuit dysfunction, recently launched by unveiling its suite of proprietary patented platforms at….
Innoviva to Acquire Entasis Therapeutics May 23, 2022
Innoviva, Inc. and Entasis Therapeutics Holdings Inc. recently announced the companies have entered into a definitive merger agreement under which Innoviva is to acquire all….
Fortress Biotech, Cyprium Therapeutics & Sentynl Therapeutics Announce the Initiation of Rolling Submission of an NDA for Treatment of Menkes Disease December 7, 2021
Cyprium Therapeutics, Inc., a Fortress Biotech, Inc. partner company, with support from its licensing partner Sentynl Therapeutics, Inc., a wholly owned subsidiary of Cadila Healthcare Limited, recently announced the initiation of a rolling submission of a New Drug Application….
Fortress Biotech Announces Closing of Acquisition of Caelum Biosciences by AstraZeneca October 12, 2021
Fortress Biotech, Inc. and a company it founded, Caelum Biosciences, Inc. recently announced the closing of AstraZeneca’s acquisition of Caelum,...Fortress Biotech Announces Exclusive Worldwide License Agreement With Columbia University May 13, 2020
Fortress Biotech, Inc. recently announced that Oncogenuity, Inc. has entered into an exclusive worldwide licensing agreement with Columbia University to develop novel….
